1
|
Guerrero-Ponce AE, Araiza J, Tirado-Sánchez A, Bonifaz A. Review Article White Piedra: Review of 131 cases. Mycoses 2024; 67:e13668. [PMID: 37907831 DOI: 10.1111/myc.13668] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2023] [Revised: 10/12/2023] [Accepted: 10/16/2023] [Indexed: 11/02/2023]
Abstract
This study analyzes the clinical characteristics of patients diagnosed with White Piedra through a systematic review of cases in the literature. A sample of 131 subjects was considered, of which 91.6% were female and most were 18 years of age or younger. Most studies were conducted in Brazil, followed by India, and Mexico. The most common etiologic agent found was Trichosporon spp (34.3%). Most affected patients were asymptomatic (94.6%) and predisposing factors included long hair, use of a hair band or hair accessories, and wet hair. The most common clinical feature was the presence of nodules. The evaluation of treatment effectiveness was hindered by the scarcity of follow-up information in the majority of the studies. It is concluded that White Piedra infection is more common in young women and is associated with hair-related factors.
Collapse
Affiliation(s)
| | - Javier Araiza
- Mycology Department, Hospital General de México Dr. Eduardo Liceaga, Mexico City, Mexico
| | - Andrés Tirado-Sánchez
- Internal Medicine Department, Hospital General de Zona 29, Instituto Mexicano del Seguro Social, Mexico City, Mexico
| | - Alexandro Bonifaz
- Dermatology Service, Hospital General de México Dr. Eduardo Liceaga, Mexico City, Mexico
- Mycology Department, Hospital General de México Dr. Eduardo Liceaga, Mexico City, Mexico
| |
Collapse
|
2
|
Tirado-Sánchez A, Bonifaz A, Frías De León MG. Factors Associated with Candidiasis in Pemphigus Vulgaris Patients: Results from a Retrospective Study in Two Second-Care Level Hospitals in Mexico. Trop Med Infect Dis 2023; 8:521. [PMID: 38133453 PMCID: PMC10748257 DOI: 10.3390/tropicalmed8120521] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2023] [Revised: 12/06/2023] [Accepted: 12/14/2023] [Indexed: 12/23/2023] Open
Abstract
BACKGROUND Infections are a major cause of morbidity and mortality in patients with pemphigus vulgaris (PV). One of the most common infections in these patients is candidiasis. This is probably due to the use of systemic immunosuppressants, including oral and intravenous corticosteroids, mainly in megadoses (pulse therapy), although it is unknown if there are other associated factors, in addition to immunosuppressive treatment. We determine the factors associated with candidiasis in PV patients in two second-care level hospitals in Mexico. METHODS We reviewed 100 cases with PV. Cases were randomly selected from the databases of two second-care level hospitals between January 2010 and December 2019 (10 years). The primary endpoint was the incidence of candidiasis in patients with PV. RESULTS One hundred patients with PV were enrolled in this retrospective study. Candidiasis was observed in 79 patients (79%). A maximum corticosteroid dose of 55 mg/day during the last year (p = 0.001) and a higher neutrophil/lymphocyte ratio were associated with candidiasis in patients with PV (p = 0.001). CONCLUSION Risk factors favoring candidiasis in patients with PV are not only related to the use of corticosteroids, but also to demographic factors, the activity of the disease, and the systemic inflammation associated with autoimmunity.
Collapse
Affiliation(s)
- Andrés Tirado-Sánchez
- Internal Medicine Department, Hospital General de Zona 30, Instituto Mexicano del Seguro Social, Mexico City 08300, Mexico
| | - Alexandro Bonifaz
- Laboratorio de Micología, Hospital General de México, Mexico City 06720, Mexico;
| | | |
Collapse
|
3
|
Peçanha-Pietrobom PM, Tirado-Sánchez A, Gonçalves SS, Bonifaz A, Colombo AL. Diagnosis and Treatment of Pulmonary Coccidioidomycosis and Paracoccidioidomycosis. J Fungi (Basel) 2023; 9:218. [PMID: 36836333 PMCID: PMC9959547 DOI: 10.3390/jof9020218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2022] [Revised: 01/31/2023] [Accepted: 02/02/2023] [Indexed: 02/10/2023] Open
Abstract
Coccidioidomycosis (CM) and paracoccidioidomycosis (PCM) are systemic mycoses that are highly endemic in Latin America and have recently been included on the World Health Organization (WHO) Fungal Priority Pathogens List. Coccidioides immitis and Coccidioides posadasii are recognized as etiological agents of CM, with peculiarities in their geographic distribution. The genus Paracoccidioides now includes Paracoccidioides lutzii and the Paracoccidioides brasiliensis complex, which encompasses four phylogenetic species. In both diseases, pulmonary signs and symptoms are the main reasons for patients to seek medical assistance, and they are frequently misdiagnosed as tuberculosis. In this paper, we present a critical view of the strategies for diagnosis and clinical management of CM and PCM. Over the past few decades, there has been an increase in the number of reports of endemic fungal infections in areas previously thought to be "non-endemic" due to climate change and increased travel, among other factors. Learning to recognize their main epidemiological aspects and clinical manifestations is crucial so that clinicians can include them in the differential diagnosis of lung disease and avoid late diagnosis.
Collapse
Affiliation(s)
| | - Andrés Tirado-Sánchez
- Dermatology Service & Mycology Department, Hospital General de México, “Dr. Eduardo Liceaga”, Mexico City 06726, Mexico
- Internal Medicine Department, Hospital General de Zona 29, Instituto Mexicano del Seguro Social, Mexico City 07950, Mexico
| | - Sarah Santos Gonçalves
- Department of Pathology, Infectious Diseases Postgraduate Program, Federal University of Espírito Santo (UFES), Vitoria 29043900, Brazil
| | - Alexandro Bonifaz
- Internal Medicine Department, Hospital General de Zona 29, Instituto Mexicano del Seguro Social, Mexico City 07950, Mexico
| | - Arnaldo Lopes Colombo
- Department of Medicine, Division of Infectious Diseases, Federal University of São Paulo (UNIFESP), São Paulo 04039032, Brazil
| |
Collapse
|
4
|
Bonifaz A, Tirado-Sánchez A, Araiza J, Hernández-Medel ML. Mucormycosis in the COVID-19 scenario beyond hospitalized patients. Future Microbiol 2023; 18:5-8. [PMID: 36648217 DOI: 10.2217/fmb-2022-0147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023] Open
Affiliation(s)
- Alexandro Bonifaz
- Hospital General de México, Dr Eduardo Liceaga, 06720, Mexico City, Mexico
| | - Andrés Tirado-Sánchez
- Hospital General de México, Dr Eduardo Liceaga, 06720, Mexico City, Mexico.,Hospital General de Zona 30, IMSS, 08300, Mexico City, Mexico
| | - Javier Araiza
- Hospital General de México, Dr Eduardo Liceaga, 06720, Mexico City, Mexico
| | | |
Collapse
|
5
|
Arteaga D, Tirado-Sánchez A, Vázquez-González D, Moreno LM, van de Sande W, Bonifaz A. Encapsulated eumycetoma caused by Biatriospora mackinnonii. Med Mycol Case Rep 2022; 38:1-4. [PMID: 36160296 PMCID: PMC9489879 DOI: 10.1016/j.mmcr.2022.08.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2022] [Revised: 08/21/2022] [Accepted: 08/28/2022] [Indexed: 11/23/2022] Open
Abstract
Eumycetoma is a chronic infection due to filamentous fungi. Herein, we report a case of eumycetoma presenting as a subcutaneous encapsulated lesion on the right leg with no previous traumatic implantation. From microscopic morphological characteristics and molecular analysis, the pathogenic fungal species were identified as Biatriospora mackinnonii. Surgical excision of the entire lesion was performed to reduce the fungal load and improve antifungal therapy response.
Collapse
Affiliation(s)
- Daniela Arteaga
- Dermatology Department, Hospital General de México Dr. Eduardo Liceaga, Mexico City, 06720, Mexico
| | - Andrés Tirado-Sánchez
- Dermatology Department, Hospital General de México Dr. Eduardo Liceaga, Mexico City, 06720, Mexico
| | - Denisse Vázquez-González
- Dermatology Department, Hospital General de México Dr. Eduardo Liceaga, Mexico City, 06720, Mexico
| | - Luis-Miguel Moreno
- Dermatopathology Department, Hospital General de México Dr. Eduardo Liceaga, Mexico City, 06720, Mexico
| | - Wendy van de Sande
- Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, Rotterdam, 3015, the Netherlands
| | - Alexandro Bonifaz
- Dermatology Department, Hospital General de México Dr. Eduardo Liceaga, Mexico City, 06720, Mexico
| |
Collapse
|
6
|
Ugalde-Trejo NX, Delgado Moreno KP, Alfaro-Sánchez A, Tirado-Sánchez A, Bonifaz Trujillo JA. Two Feet-One Hand Syndrome: Tinea Pedis and Tinea Manuum. Curr Fungal Infect Rep 2022. [DOI: 10.1007/s12281-022-00447-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|
7
|
Gay P, Niezen S, Sáenz-Dávila B, Arellano-Mendoza I, Mercadillo P, Tirado-Sánchez A. Duloxetine-Associated Photodistributed Erythema Multiforme. Prim Care Companion CNS Disord 2022; 24. [DOI: 10.4088/pcc.21cr02983] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
8
|
Fuentes-Nava AG, Arellano-Mendoza MI, Ponce-Olivera RM, Mercadillo-Pérez P, Moreno-López LM, García-García JA, Tirado-Sánchez A. Cutaneous adnexal tumors: a 5-year retrospective, clinicopathological study in a tertiary-care hospital. Int J Dermatol 2022; 61:e342-e344. [PMID: 35106760 DOI: 10.1111/ijd.16085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/27/2021] [Revised: 12/24/2021] [Accepted: 01/06/2022] [Indexed: 11/28/2022]
Affiliation(s)
- Ana G Fuentes-Nava
- Hospital General de Mexico, Dr. Eduardo Liceaga, Ciudad de Mexico, Mexico
| | | | | | | | | | | | | |
Collapse
|
9
|
Tirado-Sánchez A, Vazquez-González D, Sáenz-Dávila B, Bonifaz A. Antifungal Vaccines: Current Status and Future Directions. Fungal Biol 2022. [DOI: 10.1007/978-3-030-89664-5_17] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
10
|
Bonifaz A, Tirado-Sánchez A, Paredes-Farrera F, Moreno-Moreno J, Araiza J, González GM. Oral involvement in mucormycosis. A retrospective study of 55 cases. Enferm Infecc Microbiol Clin (Engl Ed) 2021; 39:506-509. [PMID: 34865712 DOI: 10.1016/j.eimce.2020.09.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/28/2020] [Accepted: 09/13/2020] [Indexed: 06/13/2023]
Abstract
INTRODUCTION Mucormycosis with oral involvement (OIM) is a rare opportunistic and lethal mycosis, which has increased in the last decade and is generally associated with uncontrolled diabetes and neutropenia. METHODS A retrospective study of cases with OIM was carried out in a tertiary-care center. Mycological and histological examinations were performed, and the isolated organisms were identified by morphology and molecular biology. RESULTS Fifty-five OIM patients were included, with a median age of 38 years (61.8% males). The most frequent associated disease was type-2 diabetes mellitus (61%), followed by neutropenia due to acute lymphocytic leukemia (27%). The main presentation was palatal and mandibular ulcers (92.7%) and, to a lesser extent, gingival and lingual necrosis. The diagnosis was established by mycological and histopathological studies. The most frequent fungi isolated was Rhizopus arrhizus (67.2%). CONCLUSION OIM is a rapidly progressing disease, therefore, an early diagnosis and the proper control of predisposing factors is necessary, and consequently, contributing to improve the outcome of mucormycosis.
Collapse
Affiliation(s)
- Alexandro Bonifaz
- Dermatology Service, & Mycology Department, Hospital General de México, "Dr. Eduardo Liceaga", Mexico.
| | - Andrés Tirado-Sánchez
- Dermatology Service, & Mycology Department, Hospital General de México, "Dr. Eduardo Liceaga", Mexico
| | | | | | - Javier Araiza
- Dermatology Service, & Mycology Department, Hospital General de México, "Dr. Eduardo Liceaga", Mexico
| | | |
Collapse
|
11
|
Abstract
Sporotrichosis is a subacute or chronic mycosis predominant in tropical and subtropical regions. It is an infection of subcutaneous tissue caused by Sporothrix fungus species, but occasionally resulting in an extracutaneous condition, including osteoarticular, pulmonary, nervous central system, and ocular disease. Cases of ocular sporotrichosis are rare, but reports have been increasing in recent decades. Ocular infections usually occur in hyperendemic areas of sporotrichosis. For its classification, anatomic criteria are used. The clinical presentation is the infection in the ocular adnexal and intraocular infection. Ocular adnexa infections include palpebral, conjunctivitis, and infections of the lacrimal sac. Intraocular infection includes exogenous or endogenous endophthalmitis. Most infections in the ocular adnexal have been reported in Brazil, China and Peru, and intraocular infections are limited to the USA and Brazil. Diagnosis is performed from Sporothrix isolation in the mycological examination from ocular or skin samples. Both sporotrichosis in the ocular adnexa and intraocular infection can mimic several infectious and non-infectious medical conditions. Ocular adnexa infections are treated with potassium iodide and itraconazole. The intraocular infection is treated with amphotericin B. This review describes the clinical findings and epidemiological, diagnosis, and treatment of ocular sporotrichosis.
Collapse
Affiliation(s)
- Max Carlos Ramírez-Soto
- School of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima 15102, Peru
- Facultad de Ciencias de la Salud, Universidad Tecnológica del Perú, Lima 15046, Peru
| | - Andrés Tirado-Sánchez
- Internal Medicine Department, Hospital General de Zona 29, Instituto Mexicano del Seguro Social, Ciudad de México 07950, Mexico;
- Dermatology Service & Mycology Department, Hospital General de México, “Dr. Eduardo Liceaga”, Balmis 148, Colonia Doctores, Ciudad de México 06726, Mexico;
| | - Alexandro Bonifaz
- Dermatology Service & Mycology Department, Hospital General de México, “Dr. Eduardo Liceaga”, Balmis 148, Colonia Doctores, Ciudad de México 06726, Mexico;
| |
Collapse
|
12
|
Bonifaz A, Tirado-Sánchez A, Araiza J, Fierro-Arias L, Martínez-Gamboa A, Ponce-de-León A. Thoracic actinomycetoma: a retrospective clinical-epidemiological study of 64 cases. Trans R Soc Trop Med Hyg 2021; 115:337-339. [PMID: 33690859 DOI: 10.1093/trstmh/trab037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2020] [Revised: 01/14/2021] [Accepted: 02/13/2021] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND Actinomycetoma is a chronic granulomatous infection that follows traumatic implantation. Thoracic actinomycetoma (TA) is rare and may lead to severe complications. METHODS A retrospective study of cases of TA diagnosed from 1985 to 2019 was carried out. Each case underwent direct examination, culture and biopsy. RESULTS Sixty-four cases (12.8%) were included, with a male predominance (84.3%); the main occupation was peasant farmer (71.8%) and the main site was the back (76.5%). Vertebral involvement was observed in 21.8% and pulmonary involvement in 7.8%. Nocardia brasiliensis was the main aetiological agent (53 cases, 74.5%). CONCLUSIONS TA is a poorly studied disease that can cause neurological and lung complications.
Collapse
Affiliation(s)
- Alexandro Bonifaz
- Dermatology Service & Micology Department, Hospital General de México, Dr. Balmis 148, colonia Doctores, 06720 México City, México
| | - Andrés Tirado-Sánchez
- Dermatology Service & Micology Department, Hospital General de México, Dr. Balmis 148, colonia Doctores, 06720 México City, México
| | - Javier Araiza
- Dermatology Service & Micology Department, Hospital General de México, Dr. Balmis 148, colonia Doctores, 06720 México City, México
| | - Leonel Fierro-Arias
- Dermatology Service & Micology Department, Hospital General de México, Dr. Balmis 148, colonia Doctores, 06720 México City, México
| | - Areli Martínez-Gamboa
- Clinical Microbiology Laboratory, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Av. Vasco de Quiroga 15, Belisario Domínguez Sección XVI, Tlalpan, 14080 México City, México
| | - Alfredo Ponce-de-León
- Clinical Microbiology Laboratory, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Av. Vasco de Quiroga 15, Belisario Domínguez Sección XVI, Tlalpan, 14080 México City, México
| |
Collapse
|
13
|
Bonifaz A, Tirado-Sánchez A, Mercadillo P, Moreno-López LM, Fierro-Arias L, Araiza J, González GM. Klinische und mykologische Untersuchung von 42 dermatophytischen Granulomen (Majocchi‐Granulome). J Dtsch Dermatol Ges 2021; 19:758-761. [PMID: 33979043 DOI: 10.1111/ddg.14453_g] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Alexandro Bonifaz
- Dermatology Service and Mycology Department, General Hospital of Mexico, Mexico City, Mexico
| | - Andrés Tirado-Sánchez
- Dermatology Service and Mycology Department, General Hospital of Mexico, Mexico City, Mexico
| | | | | | - Leonel Fierro-Arias
- Dermatology Service and Mycology Department, General Hospital of Mexico, Mexico City, Mexico
| | - Javier Araiza
- Dermatology Service and Mycology Department, General Hospital of Mexico, Mexico City, Mexico
| | - Gloria M González
- Microbiology Department, Medicine Faculty, Universidad Autónoma de Nuevo León, Mexico
| |
Collapse
|
14
|
Tirado-Sánchez A, Sánchez-Álvarez I, Bonifaz A. Wells syndrome (eosinophilic cellulitis). A retrospective study in 35 adult patients. Med Clin (Barc) 2021; 157:544-545. [PMID: 33985765 DOI: 10.1016/j.medcli.2021.01.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2020] [Revised: 01/02/2021] [Accepted: 01/07/2021] [Indexed: 11/17/2022]
|
15
|
Bonifaz A, Tirado-Sánchez A, Mercadillo P, Moreno-López LM, Fierro-Arias L, Araiza J, González GM. Clinical and mycological study of 42 cases of dermatophytic granuloma (Majocchi granuloma). J Dtsch Dermatol Ges 2021; 19:758-761. [PMID: 33890399 DOI: 10.1111/ddg.14453] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Alexandro Bonifaz
- Dermatology Service and Mycology Department, General Hospital of Mexico, Mexico City, Mexico
| | - Andrés Tirado-Sánchez
- Dermatology Service and Mycology Department, General Hospital of Mexico, Mexico City, Mexico
| | | | | | - Leonel Fierro-Arias
- Dermatology Service and Mycology Department, General Hospital of Mexico, Mexico City, Mexico
| | - Javier Araiza
- Dermatology Service and Mycology Department, General Hospital of Mexico, Mexico City, Mexico
| | - Gloria M González
- Microbiology Department, Medicine Faculty, Universidad Autónoma de Nuevo León, Mexico
| |
Collapse
|
16
|
Fuentes-Nava G, Tirado-Sánchez A, Fernández-Figueroa EA, Sánchez-Montes S, Becker I, Bonifaz A. Efficacy of imiquimod 5% cream as first-line management in cutaneous leishmaniasis caused by Leishmania mexicana. Rev Soc Bras Med Trop 2021; 54:e0305-2020. [PMID: 33759916 PMCID: PMC8008850 DOI: 10.1590/0037-8682-0305-2020] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2020] [Accepted: 09/02/2020] [Indexed: 11/22/2022] Open
Abstract
Cutaneous leishmaniasis (CL) involves several differential diagnoses as it lacks a gold standard diagnostic test. Its diagnosis is easier in endemic regions; however, many cases come from travelers to endemic areas. A 22-year-old patient, who had recently visited Oaxaca, Mexico, developed two asymptomatic ulcers weeks later on the left auricle and the nose. Leishmania mexicana was identified using polymerase chain reaction. The patient was treated with imiquimod 5% cream three times/week, providing favorable results after 12 weeks, without relapse 2 months after therapy. To our knowledge, this is the first case of CL due to L. mexicana effectively treated with imiquimod.
Collapse
Affiliation(s)
| | - Andrés Tirado-Sánchez
- Hospital General de México, Servicio de Dermatología, México.,Instituto Mexicano del Seguro Social, Hospital General de Zona 29, Departamento de Medicina Interna, México
| | - Edith A Fernández-Figueroa
- Instituto Nacional de Medicina Genómica, Laboratorio de Genómica Computacional, México.,Universidad Nacional Autónoma de México, Facultad de Medicina, Centro de Medicina Tropical, Unidad de Medicina Experimental, México
| | - Sokani Sánchez-Montes
- Universidad Nacional Autónoma de México, Facultad de Medicina, Centro de Medicina Tropical, Unidad de Medicina Experimental, México.,Universidad Veracruzana, Facultad de Ciencias Biológicas y Agropecuarias, México
| | - Ingeborg Becker
- Universidad Nacional Autónoma de México, Facultad de Medicina, Centro de Medicina Tropical, Unidad de Medicina Experimental, México
| | | |
Collapse
|
17
|
Tirado-Sánchez A, Aguilar-Mena C, Rodriguez-Mendoza A, Hernández-Salgado Y, Bonifaz A. Clinical-therapeutic study on the efficacy and safety of thalidomide in the management of discoid lupus erythematosus. A single-centre, retrospective study. Australas J Dermatol 2021; 62:375-379. [PMID: 33729544 DOI: 10.1111/ajd.13571] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2020] [Accepted: 01/10/2021] [Indexed: 11/29/2022]
Abstract
Thalidomide is a second-line treatment for discoid lupus erythematosus (DLE). The efficacy of this treatment, the minimum effective doses, and safety is poorly documented in the literature. The aim of the study was to determine the efficacy and tolerance of thalidomide as first or second line of therapy for discoid lupus erythematosus. We present a retrospective single-centre study of 68 patients with DLE treated with thalidomide from 2003 to 2019. The inclusion criteria were the presence of clinical lesions suggestive of DLE, confirmed by histological examination and direct immunofluorescence. The mean age at diagnosis was 37.45 years (range 18-65 years). Thalidomide was started an average of 2.25 years after the diagnosis of DLE, as second-line therapy in 85% of the cases (58 patients), and as first-line therapy in 10 patients (15%). Fifty-six patients improved with thalidomide (82%), 39 cases achieved complete remission and 17 partial remissions. The mean duration of follow-up with thalidomide was 8.4 months (range 3-25 months). Five patients discontinued thalidomide due to adverse events. The most frequent side effect was headache (23.5%). Thalidomide is effective and safe in DLE patients as first or second-line treatment with a good safety profile.
Collapse
|
18
|
Bonifaz A, Tirado-Sánchez A, Araiza J, Treviño-Rangel R, González GM. Deep mycoses and pseudomycoses of the foot: a single-center retrospective study of 160 cases, in a tertiary-care center in Mexico. Foot (Edinb) 2021; 46:101770. [PMID: 33453613 DOI: 10.1016/j.foot.2020.101770] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/26/2020] [Revised: 11/12/2020] [Accepted: 11/21/2020] [Indexed: 02/04/2023]
Abstract
BACKGROUND Deep mycoses and pseudomycoses (DMP) may cause significant disability and even death; however, the reports regarding these diseases, mainly affecting the foot, are scarce. OBJECTIVE To describe the epidemiological, clinical, and diagnostic characteristics of DMP of the foot in 160 patients. METHODS A retrospective and observational study of DMP affecting the foot was carried out in a tertiary-care center in Mexico for 20 years (from January 2000 to December 2019). Cases with confirmatory microbiological studies were included; the identification of the isolated fungi was based on the forms of reproduction. For actinomycetes, morphological analysis in an automated system ATB Vitek® 1574 (Biomèrieux) was used. The fungi were identified by PCR, using several primers from the ITS regions and for actinomycetes in the 16S rRNA region. Data from histopathological studies were also collected. RESULTS One hundred and sixty proven cases of DMP of the foot were included. The cases were categorized into nine types of infections including mycetoma (actinomycetoma and eumycetoma) in 102 cases (63.7%); sporotrichosis in 21 cases (13.1%); chromoblastomycosis, 18 cases (11.2%); phaeohyphomycosis, 3 cases (1.8%); histoplasmosis, 12 cases (7.5%); coccidioidomycosis 2 cases (1.2%) and botryomycosis and nocardiosis with one case respectively (0.6%). Most cases developed after traumatic implantation (147 cases, 91.8%). One hundred fifteen cases (71.8%) were men. The evolution was chronic in 125 cases (78.2%); bone involvement was observed in 64 cases (40%). Parasitic forms were observed In 139 cases (86.8%). The isolation and identification of the etiological agents were confirmed in all cases. CONCLUSION The main DMP affecting the foot were infections due to traumatic implantation; most were endemic mycoses. The clinical characteristics and the evolution of the diseases are easily misdiagnosed, and thus, diagnostic tests are usually required.
Collapse
Affiliation(s)
- Alexandro Bonifaz
- Dermatology Service, & Mycology Department, Hospital General De México, "Dr. Eduardo Liceaga", Mexico.
| | - Andrés Tirado-Sánchez
- Dermatology Service, & Mycology Department, Hospital General De México, "Dr. Eduardo Liceaga", Mexico
| | - Javier Araiza
- Dermatology Service, & Mycology Department, Hospital General De México, "Dr. Eduardo Liceaga", Mexico
| | | | | |
Collapse
|
19
|
Bonifaz A, Tirado-Sánchez A, Vazquez-Gonzalez D, Araiza J, Hernández-Castro R. Actinomycetoma by Actinomadura madurae: Clinical Characteristics and Treatment of 47 Cases. Indian Dermatol Online J 2021; 12:285-289. [PMID: 33959526 PMCID: PMC8088182 DOI: 10.4103/idoj.idoj_474_20] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2020] [Revised: 07/17/2020] [Accepted: 09/05/2020] [Indexed: 12/02/2022] Open
Abstract
Context: Mycetoma is a chronic, granulomatous disease caused by fungi (eumycetoma) or aerobic filamentous actinomycetes (actinomycetoma). Actinomadura madurae is one of the most frequent actinomycetes. Aim: The study aims to provide an update on clinical, diagnostic, therapeutic, and outcome data for patients with actinomycetoma in a single center in Mexico. Settings and Design: This was a retrospective study of 47 cases diagnosed with actinomycetoma. Subjects and Methods: The cases were selected from a total of 536 mycetoma obtained during 35 years (from 1985 to 2019). Clinical data were retrieved from the clinical records of our department. Microbiological data were obtained from our Mycology laboratory. Statistical Analysis: Frequencies and percentages were used for categorical variables. Normality was determined with the Kolmogorov–Smirnov test. We used means and medians to describe the variables. Results: Forty-seven patients with actinomycetoma were included; female:male ratio 1.9:1; median age 38 years. The foot was the most affected region in 76.5% of cases. The bone invasion was observed in 89%. The time between symptoms onset and diagnosis was 5.5 years. Grain detection by direct examination was positive in 95% of cases. The most commonly used, as well as the most effective treatment scheme was streptomycin + sulfamethoxazole-trimethoprim with dapsone. Sixty-three percent (30 patients) achieved clinical and mycological cure, and 10.6% (5 patients) had treatment failure. Conclusions: We highlight the importance of designing therapeutic strategies to standardize treatments and gain more experience to improve the care of these patients.
Collapse
Affiliation(s)
- Alexandro Bonifaz
- Department of Dermatology, Hospital General de México, Mexico City, Mexico.,Mycology Service, Hospital General de México, Mexico City, Mexico
| | - Andrés Tirado-Sánchez
- Department of Dermatology, Hospital General de México, Mexico City, Mexico.,Department of Internal Medicine, Hospital General de Zona 29, Instituto Mexicano del Seguro Social, Mexico City, Mexico
| | | | - Javier Araiza
- Department of Dermatology, Hospital General de México, Mexico City, Mexico.,Mycology Service, Hospital General de México, Mexico City, Mexico
| | | |
Collapse
|
20
|
Bonifaz A, Tirado-Sánchez A, Hernández-Medel ML, Araiza J, Kassack JJ, Del Angel-Arenas T, Moisés-Hernández JF, Paredes-Farrera F, Gómez-Apo E, Treviño-Rangel RDJ, González GM. Mucormycosis at a tertiary-care center in Mexico. A 35-year retrospective study of 214 cases. Mycoses 2020; 64:372-380. [PMID: 33253454 DOI: 10.1111/myc.13222] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2020] [Revised: 11/11/2020] [Accepted: 11/24/2020] [Indexed: 12/24/2022]
Abstract
BACKGROUND Mucormycosis is a rare, invasive disease associated with high mortality rates, produced by opportunistic pathogens related to the Mucorales order and characterised by a diverse range of clinical forms; acute rhino-orbital-cerebral and pulmonary symptoms are the most reported ones. OBJECTIVES To report the experience of mucormycosis observed in a tertiary-care hospital in Mexico for 35 years. METHODS This was a retrospective, descriptive and observational study on mucormycosis at a tertiary-care hospital in Mexico from January 1985 to December 2019. Demographic and clinical data and mycological and histopathological records were selected. RESULTS Two hundred fourteen proven cases of mucormycosis for 35 years at a tertiary-care hospital in Mexico were included. Most of the cases were male patients with a median age of 45 years. The two most associated underlying diseases were diabetes mellitus (76.6%) and haematologic malignancy (15.4%). The three primary clinical forms were as follows: rhino-orbito-cerebral (75.9%), cutaneous (8.41%) and pulmonary (7.47%) mucormycosis. The most isolated agents were Rhizopus arrhizus (58.4%) and Lichtheimia corymbifera (12.3%). The overall therapeutic response was 58.5%, and the best response was observed with amphotericin B deoxycholate and surgical debridement. CONCLUSION Mucormycosis is an emerging disease, and its incidence has increased at our hospital over the years. In this study, the rhino-cerebral clinical type was the most frequent in patients with uncontrolled diabetes; the main aetiological agent was R. arrhizus. Early diagnosis, control of the underlying disease and prompt management may increase the survival rate.
Collapse
Affiliation(s)
- Alexandro Bonifaz
- Hospital General de México "Dr. Eduardo Liceaga", Mexico City, Mexico
| | | | | | - Javier Araiza
- Hospital General de México "Dr. Eduardo Liceaga", Mexico City, Mexico
| | - Juan J Kassack
- Hospital General de México "Dr. Eduardo Liceaga", Mexico City, Mexico
| | | | | | | | - Erick Gómez-Apo
- Hospital General de México "Dr. Eduardo Liceaga", Mexico City, Mexico
| | - Rogelio de J Treviño-Rangel
- Facultad de Medicina y Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Mexico
| | - Gloria M González
- Facultad de Medicina y Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Mexico
| |
Collapse
|
21
|
Tirado-Sánchez A, Franco-Paredes C, Bonifaz A. Subcutaneous Mycoses in Travelers. Curr Trop Med Rep 2020; 7:141-152. [PMID: 35665217 PMCID: PMC9162435 DOI: 10.1007/s40475-020-00216-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/24/2020] [Indexed: 01/19/2023]
Abstract
Purpose of Review The increase in international travel in recent decades has contributed to the risk of acquiring diseases considered endemic to a region or country and the change in the epidemiology of these diseases. Endemic mycoses that may be acquired by travelers in the short or long term are endemic subcutaneous mycoses such as sporotrichosis and lobomycosis, while endemic systemic mycoses are a group of serious diseases including histoplasmosis and coccidioidomycosis. Herein, we review the current knowledge and highlight the most important aspects of these fungal infections in travelers. Recent Findings The most relevant advances in the study of these mycoses involve the epidemiological distribution; human mycoses can be fatal and there are few antifungal drugs available, increasing drug resistance, and a risk of emerging fungal diseases associated with climate change, as well as the increasing virulence, and the diagnostic strategies that may be limited in many countries. Summary Although endemic mycoses are relatively rare, they should be considered as potentially travel-related illnesses. A recent or late trip to an endemic country may guide the clinical suspicion, an early diagnosis, and the institution of effective therapy.
Collapse
Affiliation(s)
- Andrés Tirado-Sánchez
- Dermatology Service & Micology Department, Hospital General de México “Dr Eduardo Liceaga”, Dr. Balmis 148, colonia Doctores, PZ: 06720 Mexico City, Mexico
| | - Carlos Franco-Paredes
- Department of Medicine, Division of Infectious Diseases, Anschutz Medical Center, University of Colorado, Aurora, CO, USA
- Instituto Nacional de Salud, Hospital Infantil de México, Federico Gómez, Mexico City, Mexico
| | - Alexandro Bonifaz
- Dermatology Service & Micology Department, Hospital General de México “Dr Eduardo Liceaga”, Dr. Balmis 148, colonia Doctores, PZ: 06720 Mexico City, Mexico
| |
Collapse
|
22
|
Bonifaz A, Tirado-Sánchez A, Torres-Erazo D, Hernández-Castro R. Ganglionar cutaneous nocardiosis in a patient with AIDS. Int J Infect Dis 2020; 101:83-84. [DOI: 10.1016/j.ijid.2020.09.1437] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2020] [Revised: 09/13/2020] [Accepted: 09/22/2020] [Indexed: 11/26/2022] Open
|
23
|
Bonifaz A, Tirado-Sánchez A, Hernández-Medel ML, Kassack JJ, Araiza J, González GM. Mucormycosis with cutaneous involvement. A retrospective study of 115 cases at a tertiary care hospital in Mexico. Australas J Dermatol 2020; 62:162-167. [PMID: 33222179 DOI: 10.1111/ajd.13508] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2020] [Revised: 10/07/2020] [Accepted: 10/11/2020] [Indexed: 12/16/2022]
Abstract
BACKGROUND/OBJECTIVES Cutaneous mucormycosis is an emerging opportunistic mycosis caused by Mucorales. It can be divided into primary caused by trauma and secondary by extension of rhino-cerebral and disseminated cases. The objective is to present a retrospective study of cases of mucormycosis with cutaneous involvement. METHODS A retrospective and descriptive study was carried out. Mucormycosis patients were included and divided into two groups: a) Primary Cutaneous and b) Secondary Cutaneous. Mycological tests were performed; the agents were identified by morphology and molecular studies (PCR and sequencing); some cases underwent histopathology. Clinical data and response to treatment were collected. RESULTS 115 cases were included, 18 of primary, and 97 of secondary cutaneous mucormycosis. Primary cutaneous mucormycosis was most associated with adhesive bands (44.4%) and trauma from traffic accidents (33.3%). The principal clinical form was extensive and deep necrotic ulcers. Secondary cutaneous mucormycosis cases were rhino-cerebral with uncontrolled diabetes (81.4%) The most frequent clinical presentation was necrosis of the eyelid and the nose (65.9%). In both groups, the principal agent was Rhizopus arrhizus, 38.8% and 74.2% respectively. The most effective treatment was the combination of amphotericin B with surgical debridement. The clinical and mycological cure was achieved in 31.0% of primary cases, and 44.4% for secondary cases. CONCLUSION Primary cutaneous mucormycosis is caused by implantation of the Mucorales due to trauma or rupture of the cutaneous barrier-breach, and secondary cutaneous mucormycosis develops as part of the rhino-cerebral process. The response to treatment depends on the extension and depth, as well as the predisposing factors.
Collapse
Affiliation(s)
- Alexandro Bonifaz
- Dermatology Service & Mycology department, Hospital General de México, "Dr Eduardo Liceaga", Mexico City, Mexico
| | - Andrés Tirado-Sánchez
- Dermatology Service & Mycology department, Hospital General de México, "Dr Eduardo Liceaga", Mexico City, Mexico
| | - María L Hernández-Medel
- Infectology Service, Hospital General de México, "Dr Eduardo Liceaga", Ciudad de Mexico, Mexico
| | - Juan J Kassack
- Hematology Service, Hospital General de México, "Dr Eduardo Liceaga", Ciudad de Mexico, Mexico
| | - Javier Araiza
- Dermatology Service & Mycology department, Hospital General de México, "Dr Eduardo Liceaga", Mexico City, Mexico
| | - Gloria M González
- Facultad de Medicina, Microbiology Department, Universidad Autónoma de Nuevo León, San Nicolas de los Garza, Mexico
| |
Collapse
|
24
|
Bonifaz A, Fernández-Samar D, Tirado-Sánchez A, Vázquez-González D, Mercadillo-Pérez P. Hidradenitis suppurativa associated with actinomycosis owing to Actinomyces meyeri. Br J Dermatol 2020; 184:e123-e124. [PMID: 33140414 DOI: 10.1111/bjd.19600] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2020] [Revised: 09/15/2020] [Accepted: 09/21/2020] [Indexed: 11/28/2022]
Affiliation(s)
- A Bonifaz
- Servicio de Dermatología y Departamento de Micología, Hospital General de México "Dr. Eduardo Licega", Mexico City, Mexico
| | - D Fernández-Samar
- Servicio de Dermatología y Departamento de Micología, Hospital General de México "Dr. Eduardo Licega", Mexico City, Mexico
| | - A Tirado-Sánchez
- Servicio de Dermatología y Departamento de Micología, Hospital General de México "Dr. Eduardo Licega", Mexico City, Mexico
| | - D Vázquez-González
- Servicio de Dermatología y Departamento de Micología, Hospital General de México "Dr. Eduardo Licega", Mexico City, Mexico
| | - P Mercadillo-Pérez
- Departamento de Dermatopatología, Hospital General de México "Dr. Eduardo Licega", Mexico City, Mexico
| |
Collapse
|
25
|
Bonifaz A, Tirado-Sánchez A, Paredes-Farrera F, Moreno-Moreno J, Araiza J, González GM. Oral involvement in mucormycosis. A retrospective study of 55 cases. Enferm Infecc Microbiol Clin 2020; 39:S0213-005X(20)30293-7. [PMID: 33158598 DOI: 10.1016/j.eimc.2020.09.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2020] [Revised: 09/07/2020] [Accepted: 09/13/2020] [Indexed: 11/29/2022]
Abstract
INTRODUCTION Mucormycosis with oral involvement (OIM) is a rare opportunistic and lethal mycosis, which has increased in the last decade and is generally associated with uncontrolled diabetes and neutropenia. METHODS A retrospective study of cases with OIM was carried out in a tertiary-care center. Mycological and histological examinations were performed, and the isolated organisms were identified by morphology and molecular biology. RESULTS Fifty-five OIM patients were included, with a median age of 38 years (61.8% males). The most frequent associated disease was type-2 diabetes mellitus (61%), followed by neutropenia due to acute lymphocytic leukemia (27%). The main presentation was palatal and mandibular ulcers (92.7%) and, to a lesser extent, gingival and lingual necrosis. The diagnosis was established by mycological and histopathological studies. The most frequent fungi isolated was Rhizopus arrhizus (67.2%). CONCLUSION OIM is a rapidly progressing disease, therefore, an early diagnosis and the proper control of predisposing factors is necessary, and consequently, contributing to improve the outcome of mucormycosis.
Collapse
Affiliation(s)
- Alexandro Bonifaz
- Dermatology Service, & Mycology Department, Hospital General de México, "Dr. Eduardo Liceaga", Mexico.
| | - Andrés Tirado-Sánchez
- Dermatology Service, & Mycology Department, Hospital General de México, "Dr. Eduardo Liceaga", Mexico
| | | | | | - Javier Araiza
- Dermatology Service, & Mycology Department, Hospital General de México, "Dr. Eduardo Liceaga", Mexico
| | | |
Collapse
|
26
|
Abstract
INTRODUCTION The global frequency of endemic mycoses has considerably increased, mainly due to environmental changes, population growth in endemic areas, and the increase in HIV-related immunosuppressed status. Among the most frequent endemic mycoses are coccidioidomycosis in semi-desert climates, and paracoccidioidomycosis, and histoplasmosis in tropical climates. The inoculum can enter the host through the airway or directly through the skin. Lymphatic and hematogenous spread may involve the skin. AREAS COVERED In this article, we provide up-to-date epidemiological and diagnostic data on major (histoplasmosis, paracoccidioidomycosis, coccidioidomycosis, blastomycosis) and minor (talaromycosis, adiaspiromycosis, emergomycosis) endemic mycoses. EXPERT OPINION Endemic mycoses include diseases with a localized endemic area, and a few of them converge. These mycoses all have in common the airway involvement and can cause pulmonary symptoms following initial asymptomatic infection. Among the risk groups to acquire these mycoses are travelers from endemic areas, archeologists, speleologists, and immigrants. Promising and useful diagnostic tools have been developed in endemic mycoses; however, most of them are not standardized or available in low-income countries.
Collapse
Affiliation(s)
- Andrés Tirado-Sánchez
- Dermatology Service, Hospital General De México "Dr. Eduardo Liceaga" , Mexico City, CP, Mexico.,Internal Medicine Department, Hospital General De Zona 29, Instituto Mexicano Del Seguro Social ., Mexico City, CP, Mexico
| | - Gloria M González
- Departamento De Microbiología, Facultad De Medicina, Universidad Autónoma De Nuevo León , San Nicolas De Los Garza, Mexico
| | - Alexandro Bonifaz
- Dermatology Service, Hospital General De México "Dr. Eduardo Liceaga" , Mexico City, CP, Mexico.,Mycology Department, Hospital General De México "Dr. Eduardo Liceaga" , Mexico City, CP, Mexico
| |
Collapse
|
27
|
Bonifaz A, Tirado-Sánchez A, Vázquez-González D, Fierro-Arias L, Araiza J, González GM. Actinomycetoma by Actinomadura madurae. Clinical and therapeutic characteristics of 18 cases with two treatment modalities. J DERMATOL TREAT 2020; 33:954-958. [PMID: 32643472 DOI: 10.1080/09546634.2020.1793887] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
BACKGROUND Actinomycetoma due to Actinomadura madurae is susceptible to numerous chemotherapeutic agents, however, the response to those treatments is variable and closely related to several factors. OBJECTIVE We aimed to evaluate the clinical-therapeutic characteristics of patients with actinomycetoma due to Actinomadura madurae with two treatment modalities. METHODS This was a retrospective study of eighteen patients with a diagnosis of actinomycetoma. The most widely used therapeutic scheme was streptomycin 1 g every third day plus TMP/SMX 800 mg/160 mg/12h, followed by TMP/SMX with DDS 100 mg/day. In six patients (33%), ciprofloxacin 500 mg every 12 h was used instead of DDS. RESULTS Conventional scheme achieved clinical and mycological cure in 58% of the cases, improvement in 16%, and 25% of the patients failed to treatment; in the cases treated with ciprofloxacin, clinical and microbiological cure was achieved in 83% of patients and clinical improvement in 16%. The treatment time to achieve clinical and mycological did not have a statistically significant difference (median 10 ± 1.38 vs. 12 ± 4.6). CONCLUSION Treatment based on streptomycin + TMP/SMX with ciprofloxacin was found to be effective in treating patients with actinomycetoma, and comparable to the conventional treatment with DDS in actinomycetoma due to A. madurae with minimal bone involvement.
Collapse
Affiliation(s)
- Alexandro Bonifaz
- Mycology Department, Hospital General de México. Dr. Eduardo Liceaga, Mexico City, Mexico
| | - Andrés Tirado-Sánchez
- Dermatology Service, Hospital General de México. Dr. Eduardo Liceaga, Mexico City, Mexico
| | | | - Leonel Fierro-Arias
- Mycology Department, Hospital General de México. Dr. Eduardo Liceaga, Mexico City, Mexico
| | - Javier Araiza
- Mycology Department, Hospital General de México. Dr. Eduardo Liceaga, Mexico City, Mexico
| | - Gloria M González
- Microbiology Department, Facultad de Medicina y Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico
| |
Collapse
|
28
|
Pech-Ortiz L, Maya-Aranda S, Hernández-Castro R, Xicohtencatl-Cortes J, Tirado-Sánchez A, Bonifaz A. Lacaziosis (Lobomycosis) From Southern Mexico: A Case Confirmed by Molecular Biology. Mycopathologia 2020; 185:737-739. [PMID: 32507903 DOI: 10.1007/s11046-020-00464-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2020] [Accepted: 05/27/2020] [Indexed: 12/01/2022]
Affiliation(s)
| | | | | | - Juan Xicohtencatl-Cortes
- Laboratory of Intestinal Bacteriology, Hospital Infantil de México Dr. Federico Gómez, Mexico City, Mexico
| | - Andrés Tirado-Sánchez
- Dermatology Department and Laboratory of Mycology, Hospital General de México "Dr. Eduardo Liceaga", Mexico City, Mexico
| | - Alexandro Bonifaz
- Dermatology Department and Laboratory of Mycology, Hospital General de México "Dr. Eduardo Liceaga", Mexico City, Mexico.
| |
Collapse
|
29
|
Bonifaz A, Morales-Peña N, Tirado-Sánchez A, Jiménez-Mendoza DR, Treviño-Rangel RJ, González GM. Atypical sporotrichosis related to Sporothrix mexicana. Mycopathologia 2020; 185:733-735. [PMID: 32500311 DOI: 10.1007/s11046-020-00463-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2020] [Accepted: 05/26/2020] [Indexed: 11/28/2022]
Affiliation(s)
- Alexandro Bonifaz
- Servicio de Dermatología and Micología, Hospital General de México "Dr. Eduardo Liceaga", Mexico City, Mexico.
| | - Neredi Morales-Peña
- Servicio de Dermatología and Micología, Hospital General de México "Dr. Eduardo Liceaga", Mexico City, Mexico
| | - Andrés Tirado-Sánchez
- Servicio de Dermatología and Micología, Hospital General de México "Dr. Eduardo Liceaga", Mexico City, Mexico
| | - Dayra R Jiménez-Mendoza
- Servicio de Dermatología and Micología, Hospital General de México "Dr. Eduardo Liceaga", Mexico City, Mexico
| | | | - Gloria M González
- Departamento de Microbiología, Facultad de Medicina de Nuevo León, Monterrey, Mexico
| |
Collapse
|
30
|
Tirado-Sánchez A, Bonifaz A. Simultaneous Bullous Pemphigoid and Vitiligo Associated with Adalimumab Therapy in a Patient with Psoriasis Vulgaris. Indian Dermatol Online J 2020; 11:229-231. [PMID: 32477986 PMCID: PMC7247621 DOI: 10.4103/idoj.idoj_53_19] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
Antitumor necrosis factors (TNFs) agents are increasingly being used for the effective treatment of diverse diseases. Due to its extensive use and longer duartion of treatment, there are a growing number of reports of the development of autoimmune conditions such as systemic lupus erythematosus, bullous pemphigoid (BP), and vitiligo associated with the use of anti-TNF agents. We describe a patient who developed BP as well as vitiligo after receiving treatment with adalimumab for plaque psoriasis. To our knowledge, this is the first case of simultaneous presentation of two diseases related to the use of adalimumab, and this highlights the importance of monitoring for more than one autoimmune event during TNF inhibition treatment.
Collapse
Affiliation(s)
- Andrés Tirado-Sánchez
- Department of Dermatology, Hospital General de México, Ciudad de México, CDMX, Mexico.,Department of Internal Medicine, Hospital General de Zona 29, IMSS, Mexico
| | - Alexandro Bonifaz
- Department of Dermatology, Hospital General de México, Ciudad de México, CDMX, Mexico
| |
Collapse
|
31
|
Affiliation(s)
- Alexandro Bonifaz
- Department of Dermatology and Mycology, Hospital General de Mexico Dr. Eduardo Liceaga, Mexico City, Mexico
| | - Andrés Tirado-Sánchez
- Department of Dermatology and Mycology, Hospital General de Mexico Dr. Eduardo Liceaga, Mexico City, Mexico
| | - Gloria M González
- Department of Microbiology, School of Medicine, Universidad Autónoma de Nuevo León, San Nicolas de los Garza, Mexico
| |
Collapse
|
32
|
Bonifaz A, Montelongo-Martínez F, Araiza J, González GM, Treviño-Rangel R, Flores-Garduño A, Camacho-Cruz A, Tirado-Sánchez A. [Evaluation of MALDI-TOF MS for the identification of opportunistic pathogenic yeasts of clinical samples]. Rev Chilena Infectol 2019; 36:790-793. [PMID: 33660761 DOI: 10.4067/s0716-10182019000600790] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2018] [Accepted: 10/15/2019] [Indexed: 11/17/2022] Open
Abstract
MALDI-TOF MS mass spectrometry is a rapid and straightforward technique to identify microorganisms by protein analysis. The study was performed in 304 yeast isolates from superficial and deep mycoses, in order to compare three methods: conventional (biochemical and morphological), MALDI-TOF MS, and polymerase chain reaction (PCR, reference). We included 24 species with predominance of Candida spp and Cryptococcus spp. The identification by conventional methods was 258/304 strains, while by MALDI-TOF MS was: 277/304 strains (84.8% versus 91.2%, P = not significant). The Kappa coefficient comparing MALDI-TOF-MS with PCR reported excellent concordance (0.99). The sensitivity and specificity of MALDI-TOF MS for the diagnosis of opportunistic pathogenic yeasts of clinical samples were 94.6% and 99% respectively. MALDI-TOF MS is a simple, fast and reliable tool for pathogenic yeasts.
Collapse
Affiliation(s)
- Alexandro Bonifaz
- Servicio de Dermatología, Laboratorio de Micología, Hospital General de México, México
| | | | - Javier Araiza
- Servicio de Dermatología, Laboratorio de Micología, Hospital General de México, México
| | - Gloria María González
- Departamento de Microbiología, Facultad de Medicina, Universidad Autónoma Nuevo León, Monterrey, México
| | - Rogelio Treviño-Rangel
- Departamento de Microbiología, Facultad de Medicina, Universidad Autónoma Nuevo León, Monterrey, México
| | - Alejandro Flores-Garduño
- Servicio de Laboratorios Centrales, Laboratorio de Bacteriología, Hospital General de México, México
| | | | - Andrés Tirado-Sánchez
- Servicio de Dermatología, Laboratorio de Micología, Hospital General de México, México
| |
Collapse
|
33
|
|
34
|
Affiliation(s)
- Alexandro Bonifaz
- Dermatology Service, Mycology Department, Hospital General de México, "Dr. Eduardo Liceaga", Mexico, Mexico
| | - Andrés Tirado-Sánchez
- Dermatology Service, Mycology Department, Hospital General de México, "Dr. Eduardo Liceaga", Mexico, Mexico
| | - Patricia Mercadillo
- Dermatopathology Service, Hospital General de México. "Dr. Eduardo Liceaga", Mexico, Mexico
| | - Leonel Fierro-Arias
- Dermatology Service, Mycology Department, Hospital General de México, "Dr. Eduardo Liceaga", Mexico, Mexico
| |
Collapse
|
35
|
Tirado-Sánchez A, Bonifaz A, Ponce-Olivera RM. Usefulness of the soluble membrane attack complex to determine dermatomyositis clinical activity and treatment response. GAC MED MEX 2019. [DOI: 10.24875/gmm.m18000193] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
36
|
Bonifaz A, Córdoba-García B, Simancas-Llanos T, Hernández MA, Martínez-Herrera E, Tirado-Sánchez A. Dermatophytosis caused by Nannizzia nana in two siblings. Rev Iberoam Micol 2019; 36:30-33. [DOI: 10.1016/j.riam.2018.02.003] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2017] [Revised: 02/01/2018] [Accepted: 02/05/2018] [Indexed: 10/27/2022] Open
|
37
|
Bonifaz A, Tirado-Sánchez A, Araiza J, Rodríguez-Leviz A, Guzmán-Sánchez D, Gutiérrez-Mendoza S, Castrejón L. White Piedra: Clinical, Mycological, and Therapeutic Experience of Fourteen Cases. Skin Appendage Disord 2018; 5:135-141. [PMID: 31049333 DOI: 10.1159/000493374] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2018] [Accepted: 08/23/2018] [Indexed: 11/19/2022] Open
Abstract
Background White piedra (WP) is an asymptomatic superficial mycosis that affects the hair stems, forming whitish nodules caused by various species of the genus Trichosporon. Objective To present a case series of WP of the head, its epidemiological data, as well as clinical, mycological, and therapeutic experience. Methods We conducted a 12-year retrospective and observational study of WP cases tested by dermoscopy, mycological study, and the identification of species through morphology, biochemistry, and proteomics (matrix-assisted laser desorption/ionization time-of-flight mass spectrometry). The treatment was based on ketoco-nazole shampoo as well as keratolytics. Results We included 14 cases of WP, all located in the head and 1 case with both head and scrotum affected. Nine cases (64.3%) presented in children aged < 15 years. The majority of the cases (13/14, 92.8%) were women. Two cases were associated with hyperkeratosis and intertrigo. Most patients had long hair and excessive moisture. In all cases hair nodules were observed and Trichosporon inkin (11/14, 78.6%) was usually isolated. Eleven cases (78.6%) were cured by administering 2% ketoconazole shampoo. Conclusion WP was observed in school-age girls. The diagnosis was based on the observation of hair nodules and its main etiologic agent was T. inkin, with good response to treatment in most cases.
Collapse
Affiliation(s)
- Alexandro Bonifaz
- Dermatology Service and Mycology Department, Hospital General de México Dr. Eduardo Liceaga, Mexico City, Mexico
| | - Andrés Tirado-Sánchez
- Dermatology Service and Mycology Department, Hospital General de México Dr. Eduardo Liceaga, Mexico City, Mexico.,Internal Medicine Department, Hospital General de Zona 29, Instituto Mexicano del Seguro Social, Mexico City, Mexico
| | - Javier Araiza
- Dermatology Service and Mycology Department, Hospital General de México Dr. Eduardo Liceaga, Mexico City, Mexico
| | - Alejandra Rodríguez-Leviz
- Pathology Laboratory (Electronic Microscopy), Hospital Infantil de México Dr. Federico Gómez, Mexico City, Mexico
| | | | | | | |
Collapse
|
38
|
Tirado-Sánchez A, Bonifaz A, Ponce-Olivera RM. [Utilidad del complejo soluble de ataque a membrana para determinar actividad clínica de la dermatomiositis y respuesta al tratamiento]. GAC MED MEX 2018; 154:582-587. [PMID: 30407468 DOI: 10.24875/gmm.18003637] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Introduction Dermatomyositis is an autoimmune disease and the most common idiopathic inflammatory myopathy. During patient follow-up, determining biochemical parameters is required in order to assess for disease activity and treatment efficacy. Objective To determine the relationship between the degree of activation of the complement system through the soluble membrane attack complex (c5b-9), dermatomyositis clinical activity and its variations with conventional treatment. Method Forty-five patients with active and inactive dermatomyositis were studied. Chemical parameters and clinical severity were established and correlated with ELISA-determined C5b-9 serum levels. Results There was positive correlation between dermatomyositis cutaneous and muscular activity and C5b-9 serum levels, which was lower than with traditional biochemical markers. In the case of treatment response, C5b-9 showed significant reduction, similar to clinical severity; with biochemical parameters, the reduction was not significant at one month of treatment with systemic steroids. Conclusions Serum levels of C5b-9 levels of C5b-9 are higher in patients with dermatomyositis than in healthy subjects; dermatomyositis active and inactive cases were determined by means of their measurement. They can be a reliable parameter of therapeutic response, more accurate than muscle enzymes measurement, particularly creatine phosphokinase.
Collapse
Affiliation(s)
- Andrés Tirado-Sánchez
- Secretaría de Salud, Hospital General de México, Servicio de Dermatología, Ciudad de México, México
| | - Alexandro Bonifaz
- Secretaría de Salud, Hospital General de México, Servicio de Dermatología, Ciudad de México, México
| | - Rosa María Ponce-Olivera
- Secretaría de Salud, Hospital General de México, Servicio de Dermatología, Ciudad de México, México
| |
Collapse
|
39
|
Ramírez-Soto MC, Bonifaz A, Tirado-Sánchez A. Endophthalmitis in patients co-infected by HIV and sporotrichosis: a systematic review of published case reports. Eye (Lond) 2018; 32:1678-1680. [DOI: 10.1038/s41433-018-0145-9] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2018] [Accepted: 04/26/2018] [Indexed: 11/09/2022] Open
|
40
|
|
41
|
Bonifaz A, Toriello C, Araiza J, Ramírez-Soto MC, Tirado-Sánchez A. Sporotrichin Skin Test for the Diagnosis of Sporotrichosis. J Fungi (Basel) 2018; 4:jof4020055. [PMID: 29747377 PMCID: PMC6023300 DOI: 10.3390/jof4020055] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2018] [Revised: 05/03/2018] [Accepted: 05/05/2018] [Indexed: 12/20/2022] Open
Abstract
Sporotrichosis is the most common implantation mycosis caused by several species of the Sporothrix schenckii complex. The gold standard for diagnosis is concerned with the isolation of the fungus; although, fresh examinations, staining, and biopsies are also helpful for this purpose. The sporotrichin is an antigenic complex comprised of a peptide-rhamnomannan, which is relevant with respect to pathogenic fungi; it is primarily used for serological and skin testing. We present a study regarding the use of sporotrichin as a diagnostic aid for cutaneous sporotrichosis. Furthermore, 138 cases with suspicion of sporotrichosis were included, 55 of which were proven through cultures. Moreover, out of these 55 cases, 52 (94.5%) tested positive for sporotrichin, while the negative cases corresponded to the disseminated cutaneous forms. We observed a sensitivity of 94.5% and a specificity of 95.2%. We consider that the use of sporotrichin as a skin test helps us as an auxiliary diagnosis before a positive sample culture.
Collapse
Affiliation(s)
- Alexandro Bonifaz
- Dermatology Service & Mycology Department, Hospital General de México, "Dr. Eduardo Liceaga", Balmis 148, Colonia Doctores, Ciudad de México 06726, Mexico.
| | - Conchita Toriello
- Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico.
| | - Javier Araiza
- Dermatology Service & Mycology Department, Hospital General de México, "Dr. Eduardo Liceaga", Balmis 148, Colonia Doctores, Ciudad de México 06726, Mexico.
| | - Max C Ramírez-Soto
- Medicine School, Universidad Nacional Mayor de San Marcos, Lima 15081, Peru.
| | - Andrés Tirado-Sánchez
- Dermatology Service & Mycology Department, Hospital General de México, "Dr. Eduardo Liceaga", Balmis 148, Colonia Doctores, Ciudad de México 06726, Mexico.
- Internal Medicine Department, Hospital General de Zona 29, Instituto Mexicano del Seguro Social, Ciudad de México 07950, Mexico.
| |
Collapse
|
42
|
Saldaña M, Montes de Oca G, Tirado-Sánchez A, Mercadillo P, Arellano-Mendoza MI. Acquired ichthyosis associated with gastric adenocarcinoma. Int J Dermatol 2018; 57:713-714. [PMID: 29603207 DOI: 10.1111/ijd.13988] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/17/2017] [Revised: 01/21/2018] [Accepted: 03/05/2018] [Indexed: 11/26/2022]
Affiliation(s)
- Mariana Saldaña
- Dermatology service General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico, Mexico
| | | | - Andrés Tirado-Sánchez
- Dermatology service General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico, Mexico
| | - Patricia Mercadillo
- Dermatopathology service General Hospital of Mexico "Dr. Eduardo Liceaga", Mexico, Mexico
| | | |
Collapse
|
43
|
Bonifaz A, Del Carmen Padilla M, Vázquez-González D, Hernández MA, Saldaña M, Hernández-Castro R, Tirado-Sánchez A. Abdominal actinomycetoma with double aetiology due to Nocardia brasiliensis and Actinomadura madurae. Eur J Dermatol 2018; 28:96-97. [PMID: 29165305 DOI: 10.1684/ejd.2017.3162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Affiliation(s)
- Alexandro Bonifaz
- Dermatology Service and Mycology Department, Hospital General de México "Dr. Eduardo Liceaga"
| | | | | | - Marco A Hernández
- Dermatology Service and Mycology Department, Hospital General de México "Dr. Eduardo Liceaga"
| | - Mariana Saldaña
- Dermatology Service and Mycology Department, Hospital General de México "Dr. Eduardo Liceaga"
| | | | - Andrés Tirado-Sánchez
- Dermatology Service and Mycology Department, Hospital General de México "Dr. Eduardo Liceaga"
| |
Collapse
|
44
|
Tirado-Sánchez A, Bonifaz A. Paraneoplastic Pemphigus. A Life-Threatening Autoimmune Blistering Disease. Actas Dermo-Sifiliográficas (English Edition) 2017. [DOI: 10.1016/j.adengl.2017.04.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
45
|
Bonifaz A, Tirado-Sánchez A, Paredes-Solís V, Cepeda-Valdés R, González GM, Treviño-Rangel RJ, Fierro-Arias L. Cutaneous disseminated sporotrichosis: clinical experience of 24 cases. J Eur Acad Dermatol Venereol 2017; 32:e77-e79. [PMID: 28833587 DOI: 10.1111/jdv.14533] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- A Bonifaz
- Dermatology Service & Mycology Department, Hospital General de México, "Dr. Eduardo Liceaga", Mexico City, Mexico
| | - A Tirado-Sánchez
- Dermatology Service & Mycology Department, Hospital General de México, "Dr. Eduardo Liceaga", Mexico City, Mexico
| | - V Paredes-Solís
- Dermatologist, Hospital General Dr. Miguel Silva, Morelia, Michoacán, Mexico
| | - R Cepeda-Valdés
- Basic Sciences Department, Medical School, Universidad de Monterrey, Monterrey, Mexico
| | - G M González
- Microbiology Department, Facultad de Medicina, Universidad Autónoma de Nuevo León, Nuevo León, Mexico
| | - R J Treviño-Rangel
- Microbiology Department, Facultad de Medicina, Universidad Autónoma de Nuevo León, Nuevo León, Mexico
| | - L Fierro-Arias
- Dermatology Service & Mycology Department, Hospital General de México, "Dr. Eduardo Liceaga", Mexico City, Mexico
| |
Collapse
|
46
|
Bonifaz A, Saldaña M, Araiza J, Mercadillo P, Tirado-Sánchez A. Two simultaneous mycetomas caused by Fusarium verticillioides and Madurella mycetomatis. Rev Inst Med Trop Sao Paulo 2017; 59:e55. [PMID: 28793023 PMCID: PMC5626227 DOI: 10.1590/s1678-9946201759055] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2016] [Accepted: 05/12/2017] [Indexed: 11/21/2022] Open
Abstract
Mycetoma is a chronic granulomatous disease, classified into eumycetoma caused by fungi and actinomycetoma due to aerobic filamentous actinomycetes. Mycetoma can be found in geographic areas near the Tropic of Cancer. Mexico is one of the countries in which actinomycetoma is endemic. We report an extraordinary case of an adult male with double eumycetoma caused by Madurella mycetomatis and Fusarium verticillioides on both feet.
Collapse
Affiliation(s)
- Alexandro Bonifaz
- Hospital General de México "Dr. Eduardo Liceaga", Departamento de Micologia, Ciudad de México, México
| | - Mariana Saldaña
- Hospital General de México "Dr. Eduardo Liceaga", Servicio de Dermatología, Ciudad de México, México
| | - Javier Araiza
- Hospital General de México "Dr. Eduardo Liceaga", Departamento de Micologia, Ciudad de México, México
| | - Patricia Mercadillo
- Hospital General de México "Dr. Eduardo Liceaga", Servicio de Dermatopatología, Ciudad de México, México
| | - Andrés Tirado-Sánchez
- Hospital General de México "Dr. Eduardo Liceaga", Servicio de Dermatología, Ciudad de México, México
| |
Collapse
|
47
|
Tirado-Sánchez A, Bonifaz A. Presence of antibodies against Legionella pneumophilain patients with pemphigus vulgaris. Int J Dermatol 2017; 56:e87-e88. [DOI: 10.1111/ijd.13505] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/08/2016] [Revised: 09/16/2016] [Accepted: 09/29/2016] [Indexed: 11/28/2022]
Affiliation(s)
- Andrés Tirado-Sánchez
- Department of Dermatology; Hospital General de México; Distrito Federal México
- Department of Internal Medicine; Hospital General de Zona 29; Instituto Mexicano del Seguro Social; Distrito Federal México
| | - Alexandro Bonifaz
- Department of Dermatology; Hospital General de México; Distrito Federal México
| |
Collapse
|
48
|
Bonifaz A, Espinosa-Díaz S, Argáez J, Hernández-Castro R, Xicohtencatl-Cortes J, Tirado-Sánchez A. Actinomycetoma due to Nocardia brasiliensis with extension to the ovaries. Eur J Obstet Gynecol Reprod Biol 2017; 211:224-225. [PMID: 28259373 DOI: 10.1016/j.ejogrb.2017.02.023] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2017] [Revised: 02/18/2017] [Accepted: 02/22/2017] [Indexed: 11/18/2022]
Affiliation(s)
| | | | - Jesús Argáez
- Gynecology Service, Hospital General de México "Eduardo Liceaga", Mexico
| | | | | | | |
Collapse
|
49
|
Bonifaz A, Tirado-Sánchez A. Cutaneous Disseminated and Extracutaneous Sporotrichosis: Current Status of a Complex Disease. J Fungi (Basel) 2017; 3:jof3010006. [PMID: 29371525 PMCID: PMC5715962 DOI: 10.3390/jof3010006] [Citation(s) in RCA: 51] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2016] [Revised: 01/31/2017] [Accepted: 02/07/2017] [Indexed: 01/19/2023] Open
Abstract
Sporotrichosis is an implantation or inoculation mycosis caused by species of Sporothrix schenckii complex; its main manifestations are limited to skin; however, cutaneous-disseminated, disseminated (visceral) and extracutaneous variants of sporotrichosis can be associated with immunosuppression, including HIV-AIDS, chronic alcoholism or more virulent strains. The most common extracutaneous form of sporotrichosis includes pulmonary, osteoarticular and meningeal. The laboratory diagnosis requires observing yeast forms and isolating the fungus; the two main causative agents are Sporothrix schenckii (ss) and Sporothrix brasiliensis. Antibody levels and species recognition by Polimerase Chain Reaction using biological samples or cultures are also useful. The treatment of choice for most cases is amphotericin B and subsequent itraconazole for maintenance therapy.
Collapse
Affiliation(s)
- Alexandro Bonifaz
- Dermatology Service, Mycology Department, Hospital General de México "Eduardo Liceaga", Balmis 148, Colonia Doctores, CP: 03020. Cd. de México, México.
| | - Andrés Tirado-Sánchez
- Dermatology Service, Mycology Department, Hospital General de México "Eduardo Liceaga", Balmis 148, Colonia Doctores, CP: 03020. Cd. de México, México.
| |
Collapse
|
50
|
Al-Hatmi AMS, Bonifaz A, Tirado-Sánchez A, Meis JF, de Hoog GS, Ahmed SA. Fusarium species causing eumycetoma: Report of two cases and comprehensive review of the literature. Mycoses 2016; 60:204-212. [PMID: 27928841 DOI: 10.1111/myc.12590] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2016] [Revised: 11/12/2016] [Accepted: 11/13/2016] [Indexed: 12/17/2022]
Abstract
Recently, mycetoma was added to the World Health Organization's list of neglected tropical disease priorities. Fusarium as a genus has been reported to cause eumycetoma, but little is known about the species involved in this infection and their identification. In this study, molecular tools were applied to identify Fusarium agents from human eumycetoma cases. The partial translation elongation factor 1-alpha (TEF-1α) gene was used as diagnostic parameter. Two additional cases of eumycetoma, due to F. keratoplasticum and F. pseudensiforme, respectively, are presented. A systematic literature review was performed to assess general features, identification, treatment and outcome of eumycetoma infections due to Fusarium species. Of the 20 reviewed patients, the majority (75%) were male. Most agents belonged to the F. solani species complex, ie F. keratoplasticum, F. pseudensiforme, and an undescribed lineage of F. solani. In addition, F. thapsinum, a member of Fusarium fujikuroi species complex was encountered. The main antifungal drugs used were itraconazole, ketoconazole and amphotericin B, but cure rates were low (15%). Partial response or relapse was observed in some cases, and a case ended in amputation. Clinical management of eumycetoma due to Fusarium is complex and combination therapy might be required to increase cure rates.
Collapse
Affiliation(s)
- Abdullah M S Al-Hatmi
- CBS-KNAW Fungal Biodiversity Centre, Utrecht, The Netherlands.,Institute of Biodiversity and Ecosystem Dynamics, University of Amsterdam, Amsterdam, The Netherlands.,Directorate General of Health Services, Ibri Hospital, Ministry of Health, Muscat, Oman
| | | | | | - Jacques F Meis
- Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital (CWZ), Nijmegen, The Netherlands.,Centre of Expertise in Mycology Radboudumc/CWZ, Nijmegen, The Netherlands
| | - G Sybren de Hoog
- CBS-KNAW Fungal Biodiversity Centre, Utrecht, The Netherlands.,Institute of Biodiversity and Ecosystem Dynamics, University of Amsterdam, Amsterdam, The Netherlands.,Basic Pathology Department, Federal University of Paraná State, Curitiba, Brazil.,Biology Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Sarah A Ahmed
- Faculty of Medical Laboratory Sciences, University of Khartoum, Khartoum, Sudan
| |
Collapse
|